在瘤新血管化中N6-甲基氨酸的作用
Lu Zhao1,2, Qinshan Li3,4, Tongliang Zhou1
1Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.
Cell death & disease
|August 4, 2024
概括
N6-甲基氨酸 (m6A) 修饰对于瘤新血管化至关重要,影响血管形成和瘤生长. 针对m6A调节剂提供了一个有前途的策略,以加强抗血管生成疗法和打击癌症进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 瘤新血管化对于瘤生长,入侵和转移至关重要.
- N6-甲基氨酸 (m6A) 修饰在调节瘤新血管化过程中起着重要作用.
- 了解m6A的作用是开发新型抗癌策略的关键.
研究的目的:
- 审查m6A在瘤新血管化中的机制,重点关注血管生成和血管仿真 (VM).
- 探索m6A调节器 (写字器,擦拭器,阅读器) 在调节血管生成因子和信号通路中的作用.
- 讨论针对m6A用于癌症治疗和克服耐药性的治疗潜力.
主要方法:
- 关于m6A修饰和瘤新血管化的研究的文献综述.
- 分析m6A对血管内皮生长因子 (VEGF) 稳定性和翻译的影响.
- 检查m6A在PI3K/AKT,MAPK和Hippo信号通路中的参与.
主要成果:
- 一种修饰通过调节血管生成因子和信号通路来影响血管生成和VM.
- 一种调节器 (写字器,擦拭器,阅读器) 参与控制瘤血管化.
- m6A有助于抵抗抗血管生成疗法.
结论:
- 针对m6A调节剂提出了癌症治疗的新治疗策略.
- 调节m6A可以提高现有的抗血管生成疗法的疗效.
- 对m6A的进一步研究对于开发有效的癌症治疗和克服耐药性至关重要.
更多相关视频
08:56A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
10.9K
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.8K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
